共 50 条
- [44] Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma Journal of Cancer Research and Clinical Oncology, 150
- [46] Considerations with newer regimens for indolent non-Hodgkin lymphoma CLINICAL LYMPHOMA & MYELOMA, 2008, 8 : S128 - S136
- [48] Treatment of Indolent Non-Hodgkin’s Lymphoma with Cladribine as Single-Agent Therapy and in Combination with Mitoxantrone International Journal of Hematology, 2004, 79 : 311 - 321